Recruiting CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation NCT07662369 Conditions Haplo-identical HCT, Hematologic Diseases, Hematologic Malignancy, +4 more Locations Ruijin Hospital — Shanghai, SH, China View Trial Details
Not Yet Recruiting CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation NCT07672964 Conditions Haplo-identical HCT, Hematologic Diseases, Hematologic Malignancy, +4 more Locations Ruijin Hospital — Shanghai, SH, China View Trial Details
Completed Abatacept s.c. for aGVHD Prevention in Haplo-HCT NCT04686929 Conditions Abatacept, Acute-graft-versus-host Disease, Haplo-identical HCT, +1 more Locations the First Affiliated Hospital of Soochow University — Suzhou, Jiangsu, China View Trial Details
